Ultraschall Med 2011; 32(1): 46-53
DOI: 10.1055/s-0029-1245428
Originalarbeiten/Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Volumetry of Fetal Hearts using 3D Real-Time Matrix Echocardiography – In Vitro Validation Experiments and 3D Echocardiographic Studies in Fetuses

Volumenmessungen fetaler Herzen mittels 3-D-Matrix-TechnologieU. Herberg1 , S. Lück1 , B. Steinweg1 , M. Brand1 , R. Knies1 , A. Geipel2 , H. G. Trier3 , J. Breuer1
  • 1Department of Pediatric Cardiology, University of Bonn
  • 2Department of Obstetrics and Prenatal Medicine, University of Bonn
  • 3Technology in Medicine and Public Health, Scientific Society, TIMUG e. V.
Further Information

Publication History

received: 30.9.2009

accepted: 7.4.2010

Publication Date:
07 July 2010 (online)

Zusammenfassung

Ziel: Validierung der Real-time-3D-Matrix-Technologie (RT3D) für die Volumetrie von fetalen Herzen. Material und Methoden: In einer prospektiven Untersuchung an 50 Feten, davon 14 mit Herzfehlern, erfolgte die Bestimmung von Ventrikelvolumina mittels RT 3D im Vergleich zur 2D-Echokardiografie (2D). Anhand kleiner Phantome und Ballons von 0,5 – 20 ml erfolgte die Überprüfung der Genauigkeit von Distanz, Flächen- und Volumenbestimmungen sowie eine systematische Analyse möglicher Fehlerquellen. Ergebnisse: Inter- und Intraobserver-Variabilität sind in vitro exzellent, allerdings werden sowohl in 2D wie auch in RT 3D Phantomvolumina tendenziell zu klein bestimmt, die Abweichung beträgt –5,49 % (3D) bzw. –6,857 % (2D). In vivo ist die RT 3D der 2D hinsichtlich der Intra- und Interobserver-Variabilität überlegen (bei linksventrikulären Volumina beträgt der Variationskoeffizient 8,28 % (3D) vs. 13,96 % (2D) und der Intraklassen-Korrelations-Koeffizient 0,997 vs. 0,885). Auch in vivo werden Volumina mittels 2D kleiner als mittels RT 3D gemessen (mittlere Differenz –0,38 bis –0,94 ml). Aufgrund eingeschränkter Schallfenster oder erschwerter Endokardabgrenzung konnten in 6 / 50 Fällen keine zuverlässigen 3D-Messungen erfolgen. Schlussfolgerung: Real-time-3D ist eine zuverlässige und valide Methode zur Volumenmessung normaler und kranker fetaler Herzen und ist der 2D-Echokardiografie hinsichtlich Messgenauigkeit sowie Intra- und Interobserver-Variabilität überlegen. Sie erscheint daher als vielversprechende Methode für die korrekte Beurteilung der fetalen Herzgröße und Funktion.

Abstract

Purpose: The aim of this study was to assess the feasibility, accuracy and reliability of 3D real-time echocardiography for fetal heart volumetry. Materials and Methods: Fifty unselected and consecutive fetuses, including 14 with cardiac malformations, were scanned prospectively using real-time 3D matrix technology and 2D echocardiography to determine ventricular volumes. Small phantoms as well as modified balloons (0.5 – 20 ml) were used to assess the validity of 2D and 3D distance, area and volume calculations and to study potential sources of error during data acquisition and analysis. The data was evaluated by two blinded observers. Results: In vitro, real-time 3D and 2D underestimated the actual volumes by –5.49 % (3D) and –6.86 % (2D). The intraobserver and interobserver variability were excellent. In vivo, real-time 3D was superior to 2D with regard to intraobserver and interobserver variability (mean coefficient of variation 8.28 % (3D) versus 13.96 % (2D), and mean intraclass correlation coefficient 0.997 (3D) versus 0.885 (2D) for left ventricular volumes). Similar to in vitro, in vivo 2D volumes were calculated smaller than 3D volumes (mean difference –0.39 to –0.94 ml). The ventricular volumes and stroke volumes increased exponentially with gestation. Secondary to poor imaging windows in advanced gestation or inadequate delineation of endocardial borders in small hearts at less than 19 weeks, 3D data could not be analyzed sufficiently in 6 / 50 fetuses. Conclusion: Real-time 3D using a matrix transducer is a feasible, reliable and valid method for volume determination in the fetus beyond 19 weeks of gestation. If compared to 2D, real-time 3D echocardiography provides improved accuracy of cardiac volumetry, decreases intraobserver and interobserver variability and is a promising tool for the accurate assessment of cardiac size and function.

References

  • 1 Simpson J. Echocardiographic evaluation of cardiac function in the fetus.  Prenat Diagn. 2004;  24 1081-1091
  • 2 Molina F S, Faro C, Sotiriadis A et al. Heart stroke volume and cardiac output by four-dimensional ultrasound in normal fetuses.  Ultrasound Obstet Gynecol. 2008;  32 181-187
  • 3 Lu X, Nadvoretskiy V, Bu L et al. Accuracy and Reproducibility of Real-Time Three-Dimensional Echocardiography for Assessment of Right Ventricular Volumes and Ejection Fraction in Children.  JASE. 2008;  21 84-89
  • 4 Jenkins C, Moir S, Chan J et al. Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging.  Eur Heart J. 2009;  30 98-106
  • 5 Meyer-Wittkopf M, Cole A, Cooper S G et al. Three-dimensional quantitative echocardiographic assessment of ventricular volume in healthy human fetuses and in fetuses with congenital heart disease.  J Ultrasound Med. 2001;  20 317-327
  • 6 Messing B, Cohen S M, Valsky D V et al. Fetal cardiac ventricle volumetry in the second half of gestation assessed by 4D ultrasound using STIC combined with inversion mode.  Ultrasound Obstet Gynecol. 2007;  30 142-151
  • 7 Rizzo G, Capponi A, Cavicchioni O et al. Fetal cardiac stroke volume determination by four-dimensional ultrasound with spatio-temporal image correlation compared with two-dimensional and Doppler ultrasonography.  Prenat Diagn. 2007;  27 1147-1150
  • 8 Tutschek B, Sahn D J. Three-Dimensional Echocardiography for Studies of the Fetal Heart: Present Status and Future Perspectives.  Cardiol Clin. 2007;  25 341-355
  • 9 Tutschek B, Hui L, Robertson P A et al. Fetal cardiac ventricular volumes derived from 3D/ 4D Echo: Definitive data from two different types of 3D ultrasound systems.  J Am Coll Cardiol. 2007;  49 254A
  • 10 Chaoui R, Heling K, Mielke G et al. Quality standards of the DEGUM for performance of fetal echocardiography.  Ultraschall in Med. 2008;  29 197-200
  • 11 Simpson J M, Cook A. Repeatability of echocardiographic measurements in the human fetus.  Ultrasound Obstet Gynecol. 2002;  20 332-339
  • 12 Bartko J J. Measures of agreement: a single procedure.  Stat Med. 1994;  13 737-745
  • 13 Bland J M, Altman D G. Measurement error.  BMJ. 1996;  313 744
  • 14 Mor-Avi V, Jenkins C, Kühl H et al. Real-Time 3D Echocardiographic Quantification of Left Ventricular Volumes: Multicenter Study for Validation with Magnetic Resonance Imaging.  Computers in Cardiology. 2008;  35 25-28
  • 15 Herberg U, Brand M, Trier H G et al. Accuracy of 3D-real-time echocardiography fort the assessment of small volumes and distances.  Cardiology in the Young. 2008;  18 6-7
  • 16 Uittenbogaard L B, Haak M C, Spreeuwenberg M D et al. Fetal cardiac function assessed with four-dimensional ultrasound imaging using spatiotemporal image correlation.  Ultrasound Obstet Gynecol. 2009;  33 272-281
  • 17 Steinweg B, Brand M, Bernhard C et al. Probleme der Volumenmessungen fetaler Ventrikel mittels 2D- und 3D-Echokardiographie.  Ultraschall in Med. 2006;  27 S1-74 V 14.9
  • 18 Bhat A H, Corbett V, Carpenter N et al. Fetal ventricular mass determination on three-dimensional echocardiography. Studies in normal fetuses and validation experiments.  Circulation. 2004;  110 1054-1060

Dr. Ulrike Herberg

Department of Pediatric Cardiology, University of Bonn

Adenauerallee 119

53113 Bonn

Germany

Phone: ++ 49/2 28/28 73 33 50

Fax: ++ 49/2 28/28 73 33 60

Email: ulrike.herberg@ukb.uni-bonn.de

    >